Yingli Chen
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Personalized glucose-lowering effect of chiglitazar in type 2 diabetes.
Journal: iScience
Published: July 08, 2023
Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus.
Journal: Clinical drug investigation
Published: September 22, 2017
Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: June 26, 2017
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 08, 2016
Factors of primary and secondary sulfonylurea failure in type 2 diabetic subjects.
Journal: Journal of diabetes
Published: November 25, 2016
Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese.
Journal: PloS one
Published: November 24, 2013
Human gut microbiota changes reveal the progression of glucose intolerance.
Journal: PloS one
Published: April 07, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026